Packed parking, long security lines and traffic greeted returning FDA workers on Monday, who were called back to the agency’s main White Oak campus as …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
The Food and Drug Administration is convening a meeting of outside experts on Tuesday to review exa-cel, a CRISPR-based treatment for sickle cell disease made
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): Annual Report/Forecast SCHOTT Pharma delivers on 2023 targets and continues profitable growth trajectory 26.01.2024 /